The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Lenalidomide in the treatment of relapsed primary central nervous system lymphoma (PCNSL).
Caroline Houillier
No relevant relationships to disclose
Sylvain Choquet
No relevant relationships to disclose
Valerie Touitou
No relevant relationships to disclose
Nadine Martin-Duverneuil
No relevant relationships to disclose
KhĂȘ Hoang-Xuan
No relevant relationships to disclose